| 000 | 01110 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517235956.0 | ||
| 264 | 0 | _c20191108 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a1499-2752 | ||
| 024 | 7 |
_a10.3899/jrheum.180060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFaguer, Stanislas | |
| 245 | 0 | 0 |
_aComplement C5-blocking Agent in Refractory Dermatomyositis. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _c12 2018 |
||
| 300 |
_a1710-1711 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aComplement C5 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDermatomyositis _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aThrombotic Microangiopathies _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBelliere, Julie | |
| 700 | 1 | _aRibes, David | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 45 _gno. 12 _gp. 1710-1711 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.180060 _zAvailable from publisher's website |
| 999 |
_c28839861 _d28839861 |
||